Nothing Special   »   [go: up one dir, main page]

Latest News for: eli lilly

Edit

Postpartum Depression Market Expected to rise, 2034 | Pfizer, Sage Therapeutics, Lipocine Inc, Eli Lilly ...

GetNews 28 Jan 2025
Several key pharmaceutical companies, including Pfizer, Sage Therapeutics, Lipocine Inc, Eli Lilly and Company, GSK, Canopie, Talkspace, and others, are developing novel products to improve the Postpartum Depression treatment outlook ... ....
Edit

A mixed bag on Day 2 of the DeepSeek shock, plus Eli Lilly keeps its ...

CNBC 28 Jan 2025
Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of trading ... .
Edit

Idiopathic Pulmonary Fibrosis Pipeline 2024: Therapies, MOA Insights, and Key Clinical Trial Updates by DelveInsight ...

GetNews 28 Jan 2025
... therapies to halt fibrosis progression, has announced a global licensing agreement with Eli Lilly and Company to advance MTX-463 into a Phase 2 clinical trial for idiopathic pulmonary fibrosis (IPF).
Edit

Novo Nordisk agrees to cap insulin price, give drug for free to neediest Minnesotans

Post Bulletin 27 Jan 2025
27 in the Newark, New Jersey federal court follows similar settlements last year with Eli Lilly and French drugmaker Sanofi ... Eli Lilly and Sanofi settled with Minnesota Attorney General Keith Ellison in February 2024 and July 2024, respectively.
Edit

Why isn’t Ozempic on Australia’s Pharmaceutical Benefits Scheme for weight loss? And should it be?

The Observer 27 Jan 2025
The US company Eli Lilly produces Mounjaro, which again is marketed as diabetes treatment but can also be used for off-label purposes ... Eli Lilly has said it will make a submission this year to place ...
Edit

Investors betting on the Trump trade may be missing some real risks

Business Insider 27 Jan 2025
I'm back! Fresh off my trip to Davos I'm jumping right into it ... DeepSeek hit No ... Markets ... 1 ... Eli Lilly's weight-loss wonders ... Eli Lilly's head of obesity teased a pill to rival Ozempic and a triple-threat "King Kong" injection to mimic bariatric surgery.
Edit

The endless struggles of Ghanaian businesses (Part 2): Second-class citizens

B & FT Online 27 Jan 2025
... Google), Amazon, Meta (Facebook), Berkshire Hathaway, Eli Lilly (a leading pharmaceutical company), Broadcom, Tesla, Walmart, JPMorgan Chase, Visa, UnitedHealth, Exxon Mobil, Mastercard, Oracle, etc.
Edit

Pfizer’s BRAFTOVI® Combination Regimen Demonstrates Improved Response in Patients with BRAF V600E-Mutant Metastatic Colorectal Cancer

Pharmiweb 27 Jan 2025
FDA for treatment-naïve patients with metastatic colorectal cancer with a BRAF V600E mutation ... 19.8-NE) and 14.6 months (95% CI ... 0.47, 95% CI ... Erbitux® is a registered trademark of Eli Lilly and Company and Merck KGaA, Darmstadt, Germany.
Edit

Editorial Roundup: United States

Wtop 27 Jan 2025
Excerpts from recent editorials in the United States and abroad.. ___. Jan. 26 ... Climate change is real ... ONLINE ... Drugmaker Eli Lilly raised the price on a vial of Humulin insulin from around $165 in 1997 to $1,784 in 2023, according to Campbell’s lawsuit.
Edit

Eli Lilly's head of obesity talks weight-loss innovations for 2025 — from an Ozempic-like pill ...

Business Insider 26 Jan 2025
Patrik Jonsson is an executive vice president at Eli Lilly and president of Lilly Cardiometabolic Health ... If Eli Lilly has its way, this may be the future of obesity care. Eli Lilly makes some of the most powerful weight-loss drugs in the world.
Edit

Mobility Mojo taps investor to boost accessibility in buildings

The Times/The Sunday Times 26 Jan 2025
It already works with names such as Eli Lilly, UBS and Accenture, helping them audit and improve their accessibility standards across the built environment, after establishing its reputation in the hotel sector with the likes of Dalata ... World ... AGENDA ... .
Edit

‘Skinny jabs’ are turning slimmers teetotal – and drinks companies are feeling the loss

The Observer 26 Jan 2025
While runaway demand will boost sectors such as biotech (analysts think the therapies made by firms such as Eli Lilly and Novo Nordisk will be a $100bn (£82bn) global market by 2033), it could deal a ...
Edit

Weight loss jabs made me feel so sick I thought I was going to die, ...

The Daily Mail 25 Jan 2025
It comes as a weekly self-injectable pen ... Predictably, Big Pharma has come up with an alternative – tirzepatide (brand name Mounjaro), manufactured by Eli Lilly – but it has yet to be approved by the US Food & Drug Administration for weight loss ... .
Edit

R/GA Wins Eli Lilly Social Business Amid Weight-Loss Drug Boom

Adweek 24 Jan 2025
Eli Lilly has appointed R/GA to run its social media account following ...
Edit

Why Novo Nordisk surged 14% on new weight-loss drug results

Invezz 24 Jan 2025
Investors in Eli Lilly will be closely monitoring the progress of Novo Nordisk’s amycretin, as it represents a significant advancement in the competitive field of obesity treatment and could ...

Most Viewed

×